The U.S. Justice Department announced Wednesday that Alibaba and AUS Merchant Services have reached a $600 million agreement to settle allegations that the companies failed to stop illegal pharmaceutical sales.
Federal officials say both companies did not do enough to prevent unlawful drug transactions from occurring through their services.
Alibaba had not responded to a request for comment at the time of the announcement.
